Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

Completed

• Conditions: Intestinal Anastomotic Leak; Intestinal Perforations

• Registration Number: NCT02477930
• Lead Sponsor: Baylor Research Institute

Brief Summary

The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-11-01
• Study First Submitted: 2015-06-19
• Study First Submitted QC: 2015-06-19
• Study First Posted: 2015-06-23
• Primary Completion: 2023-09-21
• Study Completion: 2023-09-21
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-21
• Last Update Posted: 2025-05-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

• All patients undergoing E-Vac Therapy
• Age > 17 years

Exclusion Criteria

• 17 years of age or younger
• Undergone an E-Vac placement > 14 days before consenting

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
In-Hospital survival-rate	6 months

Trial Locations

Locations (1)

Baylor University Medical Center; 🇺🇸 Dallas, Texas, United States